165 related articles for article (PubMed ID: 8187992)
1. [Total parenteral nutrition-related cholestatic hepatopathy, is it an infectious disease?].
Beau P; Barrioz T; Ingrand P
Gastroenterol Clin Biol; 1994; 18(1):63-7. PubMed ID: 8187992
[TBL] [Abstract][Full Text] [Related]
2. Similar liver function abnormalities occur in patients receiving glucose-based and lipid-based parenteral nutrition.
Wagner WH; Lowry AC; Silberman H
Am J Gastroenterol; 1983 Apr; 78(4):199-202. PubMed ID: 6404158
[TBL] [Abstract][Full Text] [Related]
3. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
[TBL] [Abstract][Full Text] [Related]
4. The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants.
Javid PJ; Collier S; Richardson D; Iglesias J; Gura K; Lo C; Kim HB; Duggan CP; Jaksic T
J Pediatr Surg; 2005 Jun; 40(6):1015-8. PubMed ID: 15991188
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
[TBL] [Abstract][Full Text] [Related]
6. Hepatic alterations during total parenteral nutrition in patients with inflammatory bowel disease: a possible consequence of lithocholate toxicity.
Fouin-Fortunet H; Le Quernec L; Erlinger S; Lerebours E; Colin R
Gastroenterology; 1982 May; 82(5 Pt 1):932-7. PubMed ID: 6800873
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M
Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
[TBL] [Abstract][Full Text] [Related]
8. S-adenosylmethionine in treatment of cholestasis after total parenteral nutrition: laboratory investigation and clinical application.
Li N; Zhang HH; Wang SH; Zhu WM; Ren JA; Li JS
Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):96-100. PubMed ID: 14607634
[TBL] [Abstract][Full Text] [Related]
9. Serum hepatic enzyme and bilirubin elevations during parenteral nutrition.
Grant JP; Cox CE; Kleinman LM; Maher MM; Pittman MA; Tangrea JA; Brown JH; Gross E; Beazley RM; Jones RS
Surg Gynecol Obstet; 1977 Oct; 145(4):573-80. PubMed ID: 408935
[TBL] [Abstract][Full Text] [Related]
10. Serum cholestasis markers as predictors of early outcome after liver transplantation.
Ben-Ari Z; Weiss-Schmilovitz H; Sulkes J; Brown M; Bar-Nathan N; Shaharabani E; Yussim A; Shapira Z; Tur-Kaspa R; Mor E
Clin Transplant; 2004 Apr; 18(2):130-6. PubMed ID: 15016125
[TBL] [Abstract][Full Text] [Related]
11. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.
Gura KM; Duggan CP; Collier SB; Jennings RW; Folkman J; Bistrian BR; Puder M
Pediatrics; 2006 Jul; 118(1):e197-201. PubMed ID: 16818533
[TBL] [Abstract][Full Text] [Related]
12. [Laboratory investigation and clinical application of S-adenosyl-L-methionine in the treatment of cholestasis after total parenteral nutrition].
Li N; Zhang H; Wang S; Zhu W; Ren J; Li J
Zhonghua Wai Ke Za Zhi; 2002 Jun; 40(6):407-10. PubMed ID: 12139793
[TBL] [Abstract][Full Text] [Related]
13. The impact of longitudinal intestinal lengthening and tailoring on liver function in short bowel syndrome.
Reinshagen K; Zahn K; Buch Cv; Zoeller M; Hagl CI; Ali M; Waag KL
Eur J Pediatr Surg; 2008 Aug; 18(4):249-53. PubMed ID: 18704888
[TBL] [Abstract][Full Text] [Related]
14. Cardiac hepatopathy before and after heart transplantation.
Dichtl W; Vogel W; Dunst KM; Grander W; Alber HF; Frick M; Antretter H; Laufer G; Pachinger O; Pölzl G
Transpl Int; 2005 Jun; 18(6):697-702. PubMed ID: 15910296
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
[TBL] [Abstract][Full Text] [Related]
16. Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment.
Levine A; Maayan A; Shamir R; Dinari G; Sulkes J; Sirotta L
J Pediatr Endocrinol Metab; 1999; 12(4):549-53. PubMed ID: 10417972
[TBL] [Abstract][Full Text] [Related]
17. Early use of cyclic TPN prevents further deterioration of liver functions for the TPN patients with impaired liver function.
Hwang TL; Lue MC; Chen LL
Hepatogastroenterology; 2000; 47(35):1347-50. PubMed ID: 11100349
[TBL] [Abstract][Full Text] [Related]
18. [Hepatobiliary complications of total parenteral nutrition].
Barbier J; Gineste D; Kraimps JL; Benand P; Carretier M; Beau P; Silvain C; Matuchansky C
Chirurgie; 1992; 118(1-2):47-53; discussion 53-4. PubMed ID: 1306426
[TBL] [Abstract][Full Text] [Related]
19. Predictive Value of the Aspartate Aminotransferase to Platelet Ratio Index for Parenteral Nutrition-Associated Cholestasis in Premature Infants With Intestinal Perforation.
Vongbhavit K; Underwood MA
JPEN J Parenter Enteral Nutr; 2018 May; 42(4):797-804. PubMed ID: 28792861
[TBL] [Abstract][Full Text] [Related]
20. Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease?
Beau P; Labat-Labourdette J; Ingrand P; Beauchant M
J Hepatol; 1994 Feb; 20(2):240-4. PubMed ID: 8006405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
